Resource Library
|
|
|
|||||||||
|
Powered by:
This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product.
Hairy cell leukemiaDefinitionHairy cell leukemia (HCL) is a rare cancer of the blood. It affects B cells, a type of white blood cell (lymphocyte). Alternative NamesLeukemic reticuloendotheliosis; HCL; Leukemia - hairy cell CausesHCL is caused by the abnormal growth of B cells. The cells can look "hairy" under the microscope because they have fine projections coming from their surface. HCL can lead to low numbers of normal blood cells. The cause of this disease is unknown. It affects men more often than women. The average age of onset is 55. Hairy cell leukemia is rare. Symptoms
Exams and TestsDuring a physical exam, the doctor may be able to feel a swollen spleen or liver. An abdominal CT scan may be done to confirm this swelling. A complete blood count shows low levels of white and red blood cells as well as platelets. Blood tests and a bone marrow biopsy can detect hairy cells. Flow cytometry or a test called TRAP can confirm the cancer diagnosis. TreatmentThis version of the Encyclopedia has no treatment information. Please discuss any and all treatment options for your condition with your healthcare professional. Outlook (Prognosis)Newer chemotherapy treatments have greatly improved the survival of patients with hairy cell leukemia. Most patients with hairy cell leukemia can expect to live 10 years or longer with the disease. Possible ComplicationsThe low blood counts caused by hairy cell leukemia can lead to infections, fatigue, and excessive bleeding. When to Contact a Medical ProfessionalCall your health care provider if you have significant bleeding. Also call if you have signs of infection, such as a persistent fever, cough, or general ill feeling. PreventionThere is no known way to prevent this disease. ReferencesGoldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: pp.1403-1404.
Review Date:
7/11/2008 Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
|
||||||||||













